Abstract-Atherosclerotic renal artery stenosis has a range of manifestations depending on the severity of vascular occlusion. The aim of this study was to examine whether exceeding the limits of adaptation to reduced blood flow ultimately leads to tissue hypoxia, as determined by blood oxygen level dependent MRI. We compared 3 groups of hypertensive patients, 24 with essential hypertension, 13 with "moderate" (Doppler velocities 200 -384 cm/s), and 17 with "severe" atherosclerotic renal artery stenosis (ARAS; velocities Ͼ384 cm/s and loss of functional renal tissue). Cortical and medullary blood flows and volumes were determined by multidetector computed tomography. Poststenotic kidney size and blood flow were reduced with ARAS, and tissue perfusion fell in the most severe lesions. Tissue medullary deoxyhemoglobin, as reflected by R2* values, was higher as compared with the cortex for all of the groups and did not differ between subjects with renal artery lesions and essential hypertension. By contrast, cortical R2* levels were elevated for severe ARAS (21.6Ϯ9.4 per second) as compared with either essential hypertension (17.8Ϯ2.3 per second; PϽ0.01) or moderate ARAS (15.7Ϯ2.1 per second; PϽ0.01). Changes in medullary R2* after furosemide administration tended to be blunted in severe ARAS as compared with unaffected (contralateral) kidneys. These results demonstrate that severe vascular occlusion overwhelms the capacity of the kidney to adapt to reduced blood flow, manifest as overt cortical hypoxia as measured by blood oxygen level-dependent MRI. The level of cortical hypoxia is out of proportion to the medulla and may provide a marker to identify irreversible parenchymal injury.
A therosclerotic renal artery stenosis (ARAS) produces a broad range of manifestations within the kidney, depending in part on the severity of vascular occlusion. Subcritical vascular lesions often have only minor hemodynamic effects, whereas more advanced stenoses activate pressor systems that increase arterial pressure 1 and reduce blood flow and glomerular filtration rate (GFR) in the affected kidney. 2 The remarkable stability of kidney function during antihypertensive drug therapy for renovascular hypertension is consistent with previous data demonstrating that adaptation to reduced kidney blood flow can effectively preserve tissue oxygenation and prevent progressive renal injury for many patients. 3 Because the kidney is abundantly perfused relative to oxygen needed for metabolic function, renovascular hypertension can develop without demonstrable tissue hypoxia.
Whether poststenotic kidneys eventually develop parenchymal fibrosis secondary to actual "ischemic" nephropathy continues to be debated. 4, 5 Measurement of kidney blood flow using multidetector computed tomography (CT) contrast transit times indicates that the initial fall in blood flow primarily reflects reduction in cortical and medullary tissue volumes and that actual tissue perfusion is only modestly affected in many such kidneys. 3 Despite these observations, it is equally certain that severe vascular occlusive disease sometimes leads to progressive loss of kidney function and interstitial fibrosis. 1, 6, 7 At some point, the poststenotic kidney loses function that does not reverse after restoring blood flow alone. 8 Blood oxygen level-dependent (BOLD) MRI provides the opportunity to examine regional tissue oxygenation noninvasively within the kidney in human subjects. 9 -11 Whether ARAS produces changes in tissue perfusion and/or hypoxic injury with reduced oxygenation detectable using BOLD magnetic resonance imaging (MRI) during progressively more severe vascular compromise is poorly understood. We sought to examine changes in regional kidney oxygenation over a wider range of moderate and severe atherosclerotic renal artery stenosis (RAS) using BOLD MRI. To accomplish this, we distinguished kidneys from patients with RAS as "severe" and "moderate" RAS based on ultrasound criteria and evident loss of functional tissue 12, 13 and compared these both with kidneys from patients with essential hypertension and unaffected (contralateral) kidneys from the same subjects. Our results demonstrate that progressively more severe renal artery occlusion produces both loss of regional kidney volumes and tissue perfusion associated with rising levels of cortical deoxyhemoglobin consistent with cortical hypoxia.
Methods

Patients
Patients were identified with essential hypertension (nϭ24 patients with 47 kidneys) and atherosclerotic RAS (nϭ30 patients with 13 kidneys with "moderate stenosis" and 17 kidneys with "severe stenosis"). Hypertensive patients were included using criteria for entry analogous to enrollment for Cardiovascular Outcomes for Renal Atherosclerotic Lesions as described previously. 3, 14 Diabetic patients were excluded. Informed, written consent was obtained after receiving approval from the institutional review board of the Mayo Clinic. Duplex ultrasound examinations of the renal vessels were obtained by dedicated sonographers in the Mayo Clinic ultrasound facility after an overnight fast as described previously. 15 Severe stenosis was defined as ultrasound velocities across the stenotic lesions in excess of 384 cm/s. In 3 instances, velocities could not be determined, but waveforms demonstrated advanced "tardus parvus" features in distal segmental vessels 13 with evident loss of tissue in the affected kidney (difference in long axis between stenotic and contralateral kidney Ͼ3.3 cm [range: 3.3-5.0 cm]). This velocity cutoff was selected to agree closely with reported velocity of 395 cm/s, proposed recently as an "optimal" velocity based on receiver operating curves defining high-grade stenosis for in-stent restenosis in the renal artery. 13 Among the 54 studied, 44 individuals with serum creatinine levels Յ1.7 mg/dL also were enrolled for inpatient studies including multidetector CT (MDCT) studies (nϭ20 with RAS; nϭ24 with essential hypertension [EH] ). Patients with creatinine Ͼ1.7 mg/dL were excluded from inpatient CT examinations out of concern for contrast nephrotoxicity. These patients with were referred from the Mayo Clinic Nephrology and Hypertension Division for outpatient BOLD MRI evaluation. Essential hypertension was confirmed by the absence of hemodynamically evident vascular lesions on MR angiography and/or MDCT. All of the patients but 1 received either an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker for hypertension. A 3-day inpatient protocol was performed in the clinical research unit of St Mary's Hospital (Rochester, MN). Dietary intake was regulated at 150 mEq of sodium with an isocaloric diet prepared on site.
The first study day included measurement of sodium excretion and of GFR by iothalamate clearance, as described previously. 16, 17 Blood pressure was measured by automated oscillometric recordings, including 3 values taken 3 times daily (an automated oscillometric unit, Omron blood pressure, each time blood pressure measured at 5 minutes, 7 minutes, and 9 minutes after a 5-minute rest).
On the second day, BOLD MRI examinations were performed on a GE Twin Speed Signa EXCITE 3.0T system (GE Medical Systems, Waukesha, WI) using an 8-channel torso phased array coil. 18 Three-plane single shot fast spin echo localizers were performed during suspended respiration followed by additional scout images (single shot fast spin echo) oriented parallel to the long axis of each kidney. These long axis scout images were then used to prescribe transverse BOLD images in a plane orthogonal to the long axis. BOLD imaging consisted of a 2D fast spoiled gradient echo sequence with multiple echo times. Eight echoes were obtained for each section location, with echo times ranging from 2.5 to 30.0 ms. Imaging parameters for the BOLD acquisition included the following: repetition time at 140 ms, flip angle 45°, section thickness 5 mm, imaging matrix 224ϫ160 to 192, and field of view 32 to 40 cm 2 , with 0.7 to 1.0 partial phase field of view. Image matrix and TR were adjusted in patients with limited breath hold capacity and the field of view and partial field of view adjusted according to patient size. BOLD measurements for each kidney were repeated 15 minutes later after furosemide (20 mg) administered intravenously. A gadoliniumenhanced MR angiogram was obtained after BOLD imaging to confirm the presence or absence of large vessel renal arterial disease. BOLD images were analyzed on an Advantage Windows workstation version 4.2 (GE Healthcare, Waukeshau, WI) using CineTool software (GE Healthcare). This program generates a set of parametric images of R2* from the BOLD sequence data by fitting signal intensity data from each echo on a voxel-by-voxel basis to an exponential function describing the expected signal decay as a function of echo time and solving for the unknown value of R2*, the magnetic rate of relaxation of the tissue, or the inverse of the T2* relaxation time.
For data analysis, individual anterior, lateral, and posterior regions of interest (ROIs of Ϸ60 mm 2 of surface area each) were traced in the cortex and medulla manually on the 7-ms echo time image or any other image yielding optimal contrast between cortex and medulla and then copied to the parametric R2* image to determine average values of R2* within the ROI. Four transverse axial sections were obtained that included the renal hilum, and data from a single section was analyzed. Special care was taken to ensure that each ROI fell within identifiable deep medullary and cortical sections that remained within the segment on repeat scanning after furosemide. The mean values of R2* were calculated for 3 cortical ROIs and 3 medullary ROIs, as described previously. 18 On the third day, the common femoral vein was cannulated with a 6F sheath and blood samples drawn from the right and left renal veins with a 5F pigtail Cobra catheter (Cook, Inc, Bloomington, IN) for venous oxygen and plasma renin activity. The catheter was then advanced into the right atrium for central venous injection of contrast for transit time studies using an MDCT, as described previously. 3 Additional images of already existing data were reconstructed at 0.6-mm section thickness, with a 0.3-mm overlap, at either b10f or b18f kernel settings, for quantitative vascular stenosis evaluation (quantitative CT angiography). 19 Image analysis was performed using ANALYZE (Biomedical Imaging Resource Center, Mayo Clinic, Rochester, MN). Analyses of MDCT flow studies were undertaken by selecting ROIs in cross-sectional images from the aorta, individual kidney cortex, and medulla. 20 Cortical and medullary volumes were calculated using the stereology module within ANALYZE. ROIs for the cortical and medullary regions were defined on each successive section and subsequently multiplied by section width; these were then summed to obtain cortical, medullary, and total renal volume. Quantitative evaluation of vascular stenosis was undertaken by CT angiography comparing the maximally narrowed cross-sections of the artery to proximal segments and expressed in percentage of vascular occlusion. 21 
Statistical Analysis
Results were expressed using mean values and SD. The analysis was performed with the statistical software JMP version 8.1. Comparisons between groups with essential hypertension or ARAS were performed with appropriate ANOVA. Comparisons between stenotic and contralateral kidneys were performed using paired t tests. Univariate analyses using linear regression or Pearson correlation coefficient method established the predictive factors for cortical and medullary R2* values. Multivariate modeling analyses were also applied to identify predictive variables for R2* values within kidneys affected by stenotic lesions. Different levels of ultrasound velocity were categorized, and 1-way ANOVA was used to correlate with basal cortical R2* values. A P value Ͻ0.05 was considered significant.
Results
Demographic features of the patients studied are summarized in Table 1 . Patient with severe ARAS were somewhat older. The distribution of men and women did not differ between groups. Serum creatinine was higher for patients with severe ARAS, as was systolic blood pressure despite similar antihypertensive therapy. As expected, measured GFR (iothalamate) was lower in those with severe ARAS. During inpatient studies, urinary sodium was maintained near 150 mEq daily. The levels of venous plasma renin activity from the affected kidneys increased progressively based in the severity of the vascular occlusion in these subjects, although the difference between mean values for moderate and severe RAS was not significant (Table 1) . Measured kidney size was smaller for patients with severe ARAS than for either EH or moderate ARAS, whereas the number of antihypertensive drugs and fraction treated with statin therapy did not differ between groups.
Results from quantitative MDCT measurements and renal function are summarized in Table 2 . Kidney volumes fell progressively for patients with moderate and severe stenosis. As compared with the contralateral kidney, cortical and total blood flows were reduced in both groups of stenotic kidneys, whereas medullary blood flow was measurably reduced only in patients with severe ARAS. Cortical tissue perfusion (expressed as blood flow [in milliliters per minute]/volume of tissue [in milliliters]) was reduced for patients with severe ARAS as compared with EH, as was medullary perfusion. With both kidney volume and perfusion reduced, renal blood flow and single kidney GFR in severe ARAS were lower than either EH or moderate ARAS. Although moderate and severe stenoses were defined by higher Doppler ultrasound velocities, differences in CT-defined quantitative estimates of vascular stenosis were minor.
Tissue oxygenation defined by deoxyhemoglobin, as reflected by R2* values, is summarized in Table 3 . Basal and postfurosemide medullary R2* levels were higher than cortical values for all of the subjects but did not differ between subjects with renal artery lesions and EH. By contrast, cortical R2* levels were elevated only in patients with severe ARAS. Seventy-five percent of patients with severe ARAS had cortical R2* values Ͼ17 s Ϫ1 , whereas patients with moderate ARAS had values Ͻ16 s Ϫ1 in 75% of cases. These differences persisted for cortical R2* levels when measured after administration of furosemide. Medullary R2* fell after furosemide administration for all of the groups, although the change tended to be blunted in severe ARAS as compared with unaffected kidneys (contralateral) (␦: 5.2Ϯ1.7 versus 10.5Ϯ2.2 per second; Pϭ0.07). Examples of parametric R2* maps obtained for moderate and severe ARAS are illustrated in the Figure. Renal blood flow in all of the kidneys was inversely correlated with the cortical R2* values (Pϭ0.03) but not medullary R2* values. Univariate factors in the poststenotic kidneys that predicted higher cortical R2* values were smaller kidney size (PϽ0.0001), ultrasound velocity (Pϭ0.0098), and kidney volume (P range from 0.0041 to 0.0008), followed by lower GFR (Pϭ0.04) and percentage of total renal blood flow to the kidney (Pϭ0.05). No direct relationship was evident with age, plasma renin activity, cortical perfusion, or body size.
Discussion and Perspectives
These results demonstrate progressive decrements in tissue perfusion and, for the first time, tissue cortical oxygenation as measured by BOLD MRI, with more severe occlusive vascular disease to the kidney. We defined severity of occlusive disease primarily by the higher range of velocities by Doppler ultrasound. As others have observed, even moderate reductions in blood flow produced a fall in kidney size with activation of the renin-angiotensin system. 22, 23 Despite reductions in kidney volume, moderate stenotic occlusion was associated with preservation of medullary and cortical tissue oxygenation. Experimental studies indicate that oxygen gradients between cortex and medulla reflect a complex balance of arterial flow, oxygen consumption related mainly to solute transport, and arteriovenous shunting. 24 Moderate renovascular occlusion leads to compensatory reduction in GFR and transport-related oxygen demand, thereby limiting cortical and medullary hypoxia. Our results with moderate ARAS indicating adaptation to reductions in blood flow with preserved oxygenation partly explain the fact that kidney function can remain stable during antihypertensive drug therapy, sometimes for many years. These observations are supported by results from recent trials, including the Angioplasty and Stenting for Renal Artery Lesions Trial 25 and Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis. 26 The principle new finding in the present study is that progressively severe arterial occlusion overwhelmed these adaptive changes and produced overt falls in tissue perfusion and accumulation of deoxyhemoglobin in the kidney cortex reflecting tissue hypoxia measurable in human subjects using BOLD MRI.
Because medullary regions have less blood flow than cortex and contain multiple sites with active transport, previous authors have emphasized the fact that some medullary regions function under conditions of relative oxygen depletion much of the time. [27] [28] [29] This is confirmed by direct measurements of reduced tissue oxygen tension within the medulla in experimental models. 30, 31 Remarkably, kidney tissue and renal vein oxygen levels remain stable over a range of conditions, partly related to incomplete oxygen consumption attributed to intrarenal arterial shunting. 24, 32 Hence, measured oxygen tension in the renal vein is consistently higher than that observed in medullary segments. 3, 24 Despite concerns related to the risk of worsening medullary hypoxia, 29 flow-related changes in our patients with severe ARAS were evident mainly by elevated R2* levels in the cortex associated with reduced cortical tissue perfusion. No differences in maximal R2* levels were evident within deep medullary regions, although the area of medullary ischemia expanded in some subjects (Figure) . Our observations extend previous reports suggesting that reduced cortical thickness is an important characteristic of severe atherosclerotic renal disease. 33 Moreover, these results indicate that a combined loss of cortical volume and tissue perfusion was associated with overt cortical hypoxia detectable by BOLD MRI. Our studies were performed during continued antihypertensive therapy with agents that block the renin-angiotensin system. We used this strategy because angiotensin II is known to modulate renal hemodynamics and may affect efficiency of sodium transport and associated oxygen consumption 34 and BOLD MR signaling. 35 Because many patients were taking these drugs, we elected to continue them for all of the subjects. Our results confirmed the relative depletion of oxygenated hemoglobin in deep medullary segments both for subjects with essential hypertension and in kidneys beyond stenotic lesions. Remarkably, these medullary segments demonstrated little further rise in R2* despite further reductions in blood flow and function. These results differ from acute kidney injury and elevated medullary R2* observed after exposure to nephrotoxins at lower magnet strength. 11 In part, this may reflect the fact that high R2* levels present even in normal kidneys under steady-state conditions reflect near maximal levels of hemoglobin desaturation and low levels of oxygen tension. 27 In addition, slowly developing reductions in glomerular filtration and cessation of solute transport may place an upper limit on oxygen consumption. Such a mechanism is consistent with previous observations that minimally functioning kidneys have blunted changes in R2* levels after inhibition of tubular solute transport after furosemide administration (Table  3) . 36, 37 By contrast, cortical oxygenation normally is associated with a surfeit of oxygenated hemoglobin and low R2* levels under most conditions. 36 With moderate ARAS in our patients, these levels remained stable despite measurable decrements in blood flow that developed with reduced cortical volume. Our current studies in severe stenosis suggest that sufficient loss of blood flow to reduce tissue perfusion also produced cortical hypoxia, as reflected by elevated R2* levels (Figure and Table 3 ). We interpret these data to demonstrate that even kidney cortical tissue normally perfused above levels required for metabolic function eventually reaches a limit from vascular insufficiency. Hence, rising cortical deoxyhemoglobin levels were associated with impaired tissue perfusion in severe renal artery occlusive disease.
Whether detecting cortical ischemia under these conditions signifies a threshold level leading to microvascular rarefaction and activated fibrogenic pathways is an important question. Experimental studies in a swine model of ARAS demonstrate major multiple injury pathways that alter endothelial function, lead to closure of cortical vessels, and produce inflammatory reactions. 38 Restoring blood flow alone does not reverse this process. 39 Under experimental conditions, hypoxia activates intrarenal fibrosis via pathways affecting epithelial-to-mesenchymal transition. 40 Whether changes in tissue oxygenation are primary signals triggering inflammatory and fibrogenic injury in humans with ARAS merits further study. Recent studies suggest that maneuvers to stimulate angiogenesis, such as local infusion of endothelial progenitor cells, may restore cortical vessels partially and allow repair of cortical injury. 41 We interpret our results in severe ARAS to indicate that, when vascular occlusion reaches levels that threaten cortical tissue perfusion and raise deoxyhemoglobin levels (and thereby R2* levels as measured with BOLD MR), processes of compensation became overwhelmed. As illustrated in the Figure, vascular occlusion can produce loss of viable kidney tissue. These data demonstrate for the first time that the decrease of kidney volume and tissue perfusion in severe ARAS are associated with cortical ischemia related to the severity (and possibly duration) of vascular lesions.
Limitations
These patients spanned a broad range of ages and changes in kidney size that developed over time. The precise onset and duration of vascular occlusion cannot be known with cer- CT imaging illustrates higher perfusion in the outer cortex as compared with medulla. BOLD parametric maps illustrate the gradient between cortex and medulla. Cortical areas have lower deoxyhemoglobin levels (mean: 15.7 per second for moderate ARAS) reflecting abundant oxygenation. B, Cortical R2* was higher for subjects with severe stenosis (B) as compared with both moderate (A) and essential hypertensive subjects (see Table 3 ). Deep medullary R2* levels were higher than cortical levels for all of the groups and did not differ based primarily by severity (Table 3) . Stable, albeit high, levels of medullary R2* were consistent with relative medullary oxygen depletion of functioning kidneys because of active solute transport, whereas cortical R2* levels and reduced cortical perfusion were evident only in those with the most severe occlusive disease.
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tainty. It is possible that changes in kidney oxygenation and perfusion reflect both duration and severity of vascular occlusion. Not all of the patients were candidates for inpatient studies with CT imaging, because that portion of the experimental protocol was limited to patients with serum creatinine Ͻ1.7 mg/dL out of concern for contrast toxicity. Additional factors that may affect apparent T2* (the reciprocal of R2*) under some conditions include water content, blood flow, blood pH, PCO 2 , and 2,3 diphosphoglycerate levels within renal tissue. We believe it is unlikely that these factors played a major role over the ranges of blood flow and perfusion identified by MDCT measurements. Medications, diet, and hydration were maintained uniformly for renal BOLD MRI, making us confident in the estimates of T2* and R2* levels (see Tables S1 to S3 ). Three of the most severe vascular lesions could not be quantified using duplex ultrasound but had major loss of kidney size in the affected kidney (3.3-5.0 cm length difference as compared with the contralateral kidney) and "tardus parvus" waveform in the segmental arteries.
Quantitative CT imaging demonstrated only minor average differences in lumen occlusion, but the stenoses exceeded 70% for most. Occlusive vascular lesions with ultrasound velocities at the level of Ͼ384 cm/s were associated with loss of parenchymal volume, blood flow, and reduced tissue perfusion. For such patients, cortical R2* levels, but not medullary R2* levels, were higher than both essential hypertension and the contralateral kidneys.
Conclusions
Taken together, these data demonstrate decreased cortical tissue oxygenation measured by BOLD MRI in progressively more severe renovascular occlusive disease. Oxygenation in both the cortex and medulla was preserved in "moderate" ARAS with duplex velocities Յ384 cm/s, despite measurable loss of kidney volume and blood flow. These data extend previous studies indicating that renal compensation for impaired blood flow is limited and that the most severe renal arterial occlusive lesions produce loss of function with cortical hypoxia detectable by BOLD MRI. This noninvasive method may provide a marker for identification of hypoxic parenchymal injury that is particularly important for longterm management of renovascular disease. Medullary post furosemide change 6+8.6 5+7 -1.1+10.7
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